ALB and chronic kidney disease: The responsiveness of T-cells in 1-1.5 month after 2nd dose was associated with level of albumin in CKD patients on intermittent HD (28), and was correlated with level of anti-S IgG at 1 month and 6 months after 2nd dose in CKD and patients on dialysis (43).